Psilocybin and Depression: What the UK’s Landmark Trial Actually Found For most of the last fifty years, psilocybin has lived in a strange limbo. Ancient medicine to some cultures, a countercultural symbol to others, a banned substance to governments, and — for a very long time — almost impossible to study seriously. That’s shifting again. […]
Continue Reading 🚚 Fast & Discreet Shipping Across 🇪🇺 Europe / 🇬🇧 UK
🎁 Free Shipping on Orders Over €150
Blog
Written by Joseph Santiago Exploring the science behind psychedelics, cannabis use disorder, and my personal journey after nearly 30 years of daily cannabis use. Many people start using cannabis for good reasons. Some use it to relax after a stressful day. Others use it to support sleep, reduce discomfort, spark creativity, or simply enjoy a deeper […]
Continue Reading
Psilocybin Depression Study: One Dose. 48 Hours. A New Kind of Hope. Written by Joseph Santiago A landmark Swedish psilocybin depression study just published in JAMA Network Open shows that a single dose can dramatically reduce symptoms in under two days — and keep them at bay for over three months. Here’s what the science […]
Continue Reading
A Single Psilocybin Session Offers Lasting Relief for Cancer Patients, Study Finds By Joseph Santiago For decades, patients facing cancer have not only battled the disease itself but also the crushing weight of anxiety, depression, and existential distress that so often accompany it. Traditional treatments for these psychological burdens—talk therapy, antidepressants, anti-anxiety medications—offer uneven relief. […]
Continue Reading
Germany Becomes First EU Country to Offer Psilocybin Therapy Outside Clinical Trials By Joseph Santiago Utrecht, The Netherlands — August 2025 BERLIN — On a quiet street in the German capital, a small clinic is making global headlines. Inside its pale-blue therapy rooms, patients struggling with severe depression are being offered something once reserved for […]
Continue Reading